Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
For people with opioid use:
- People aged 18 to 60 years old, male or female
- People who are already taking part in a related study called H-22611
- People whose responses to a substance use screening questionnaire (WHO-ASSIST) indicate opioid use at a score of 4 or above
- People whose responses to a depression questionnaire (PHQ-9) indicate depressive symptoms
- People whose responses to a suicide-related questionnaire (SBQ-R) indicate active suicidal thoughts
- People who are able to understand, agree to, and sign a consent form, and are willing to complete all study steps
- Female participants who are not pregnant and not breastfeeding at the time of brain scan and treatment sessions
- People with no medical or physical reasons that would make MRI scanning unsafe (such as a pacemaker, cochlear implants, or metal in the eyes or body), and who pass the pre-screening questions from the brain imaging centre
- People with no medical or physical reasons that would make brain stimulation treatment (TMS) unsafe (such as non-removable metal in the head, excluding the mouth, or within 12 inches of the treatment device)
For healthy volunteers (comparison group):
- People aged 18 to 60 years old, male or female
- People with no history of serious medical or neurological conditions
- People who are able to understand, agree to, and sign a consent form, and are willing to complete all study steps
- Female participants who are not pregnant and not breastfeeding at the time of brain scan sessions
- People with no medical or physical reasons that would make MRI scanning unsafe, and who pass the pre-screening questions from the brain imaging centre
- People with no medical or physical reasons that would make brain stimulation (TMS) unsafe
Who may not be able to join:
- People who the clinical and research team believe are unlikely to complete the study, including those who may not be able to tolerate the brain stimulation treatment
- People who are unable to understand how the study works or what it involves
- People who are unable to sign a consent form for any reason
- People with an unstable or serious medical condition, including HIV/AIDS, active hepatitis, active tuberculosis, unstable heart disease, unstable diabetes, or liver or kidney problems
- Female participants who are pregnant or breastfeeding
- People who have medical or physical reasons that make MRI scanning unsafe, or who do not pass the brain imaging centre's pre-screening questions
- People who have medical or physical reasons that make brain stimulation (TMS) unsafe, including non-removable metal in the head (excluding the mouth) or within 12 inches of the treatment device
- People who do not speak English (confirm with trial site for any updates on language support)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 713-275-5019
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Functional Connectivity between the orbitofrontal cortex (OFC) and dorsal striatum in opioid users or opioid-related patients versus healthy subjects; rTMS changes in dorsal striatum responses between those receiving active stimulation versus sham stimulation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.